Economic and Human Costs of Restless Legs Syndrome Thomas ReinholdFalk Müller-RiemenschneiderBernd Brüggenjürgen Leading Article 17 September 2012 Pages: 267 - 279
Reviewing the Cost Effectiveness of Rotavirus Vaccination Joke BilckePhilippe Beutels Review Article 17 September 2012 Pages: 281 - 297
Willingness to Pay for Cancer Prevention Timothy L. HuntBryan R. LuceRobin Pokrzywinski Review Article 17 September 2012 Pages: 299 - 312
Cost Effectiveness of Drug-Eluting Stents In Belgian Practice Mattias NeytChris De LaetHans Van Brabandt Original Research Article 17 September 2012 Pages: 313 - 327
Impact of Transdermal Oxybutynin on Work Productivity in Patients with Overactive Bladder Laura T. PizziAmy TalatiPeter K. Sand Original Research Article 17 September 2012 Pages: 329 - 339
Clinical Effectiveness and Cost Effectiveness of Tailoring Chronic Hepatitis C Treatment with Peginterferon Alpha-2b Plus Ribavirin to HCV Genotype and Early Viral Response Uwe SiebertGaby SroczynskiJohn B. Wong Original Research Article 17 September 2012 Pages: 341 - 354
